Document is current

Any future updates will be listed below

Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-408

Published Online: 2014-06-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark